Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Graph Algorithms for Condensing and Consolidating Gene Set Analysis Results.

Savage SR, Shi Z, Liao Y, Zhang B.

Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S141-S152. doi: 10.1074/mcp.TIR118.001263. Epub 2019 May 29.

2.

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.

Vasaikar S, Huang C, Wang X, Petyuk VA, Savage SR, Wen B, Dou Y, Zhang Y, Shi Z, Arshad OA, Gritsenko MA, Zimmerman LJ, McDermott JE, Clauss TR, Moore RJ, Zhao R, Monroe ME, Wang YT, Chambers MC, Slebos RJC, Lau KS, Mo Q, Ding L, Ellis M, Thiagarajan M, Kinsinger CR, Rodriguez H, Smith RD, Rodland KD, Liebler DC, Liu T, Zhang B; Clinical Proteomic Tumor Analysis Consortium.

Cell. 2019 May 2;177(4):1035-1049.e19. doi: 10.1016/j.cell.2019.03.030. Epub 2019 Apr 25.

3.

Cannabis in Pain Treatment: Clinical and Research Considerations.

Savage SR, Romero-Sandoval A, Schatman M, Wallace M, Fanciullo G, McCarberg B, Ware M.

J Pain. 2016 Jun;17(6):654-68. doi: 10.1016/j.jpain.2016.02.007. Epub 2016 Mar 4.

PMID:
26961090
4.

NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis.

Bretz CA, Savage SR, Capozzi ME, Suarez S, Penn JS.

Sci Rep. 2015 Nov 3;5:14963. doi: 10.1038/srep14963.

5.
6.

RNA-Seq reveals a role for NFAT-signaling in human retinal microvascular endothelial cells treated with TNFα.

Savage SR, Bretz CA, Penn JS.

PLoS One. 2015 Jan 24;10(1):e0116941. doi: 10.1371/journal.pone.0116941. eCollection 2015.

7.

A pain research agenda for the 21st century.

Gereau RW 4th, Sluka KA, Maixner W, Savage SR, Price TJ, Murinson BB, Sullivan MD, Fillingim RB.

J Pain. 2014 Dec;15(12):1203-14. doi: 10.1016/j.jpain.2014.09.004. Epub 2014 Oct 29.

8.

Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell types.

Watkins WM, McCollum GW, Savage SR, Capozzi ME, Penn JS, Morrison DG.

Exp Eye Res. 2013 Nov;116:240-6. doi: 10.1016/j.exer.2013.09.014. Epub 2013 Sep 26.

9.

What to do when pain and addiction coexist.

Savage SR.

J Fam Pract. 2013 Jun;62(6 Suppl):S10-6.

PMID:
23828808
10.

Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.

Capozzi ME, McCollum GW, Savage SR, Penn JS.

Invest Ophthalmol Vis Sci. 2013 Jun 19;54(6):4197-207. doi: 10.1167/iovs.13-11608.

11.

Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.

Rosenblum A, Cruciani RA, Strain EC, Cleland CM, Joseph H, Magura S, Marsch LA, McNicholas LF, Savage SR, Sundaram A, Portenoy RK.

J Opioid Manag. 2012 Nov-Dec;8(6):369-82. doi: 10.5055/jom.2012.0137.

12.

Informed consent in opioid therapy: a potential obligation and opportunity.

Cheatle MD, Savage SR.

J Pain Symptom Manage. 2012 Jul;44(1):105-16. doi: 10.1016/j.jpainsymman.2011.06.015. Epub 2012 Mar 21. Review.

13.

Fluorescent probe dyes for metabolic-ion sensing under high hydrostatic pressures.

Urayama P, Frey EW, Savage SR.

Ann N Y Acad Sci. 2010 Feb;1189:104-12. doi: 10.1111/j.1749-6632.2009.05184.x.

PMID:
20233375
14.

Management of opioid medications in patients with chronic pain and risk of substance misuse.

Savage SR.

Curr Psychiatry Rep. 2009 Oct;11(5):377-84. Review.

PMID:
19785979
15.

Challenges in using opioids to treat pain in persons with substance use disorders.

Savage SR, Kirsh KL, Passik SD.

Addict Sci Clin Pract. 2008 Jun;4(2):4-25.

16.

Definitions related to the medical use of opioids: evolution towards universal agreement.

Savage SR, Joranson DE, Covington EC, Schnoll SH, Heit HA, Gilson AM.

J Pain Symptom Manage. 2003 Jul;26(1):655-67. Review.

PMID:
12850648
17.

Assessment for addiction in pain-treatment settings.

Savage SR.

Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S28-38.

PMID:
12479252
18.

Treatment of pain in methadone-maintained patients.

Scimeca MM, Savage SR, Portenoy R, Lowinson J.

Mt Sinai J Med. 2000 Oct-Nov;67(5-6):412-22. Review.

PMID:
11064492
19.

Opioid therapy of chronic pain: assessment of consequences.

Savage SR.

Acta Anaesthesiol Scand. 1999 Oct;43(9):909-17. Review.

PMID:
10522738
20.

Opioid use in the management of chronic pain.

Savage SR.

Med Clin North Am. 1999 May;83(3):761-86. Review.

PMID:
10386124
21.

Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy--tolerance and addiction.

Portenoy RK, Savage SR.

J Pain Symptom Manage. 1997 Sep;14(3 Suppl):S27-35. Review.

PMID:
9291708
22.

Long-term opioid therapy: assessment of consequences and risks.

Savage SR.

J Pain Symptom Manage. 1996 May;11(5):274-86. Review.

PMID:
8636626
23.

Addiction in the treatment of pain: significance, recognition, and management.

Savage SR.

J Pain Symptom Manage. 1993 Jul;8(5):265-78. Review.

PMID:
7525743
24.

Preface: pain medicine and addiction medicine--controversies and collaboration.

Savage SR.

J Pain Symptom Manage. 1993 Jul;8(5):254-6. No abstract available.

PMID:
7525742
25.

Stress coping skills for the dental profession.

Savage SR, Fulmer RS, Stevens T.

J Tenn Dent Assoc. 1983 Jul;63(3):44-6. No abstract available.

PMID:
6578388

Supplemental Content

Loading ...
Support Center